CORTEXA
← Browse
openalexFrontiers in Oncology2026-07-24Cited by 0

Spontaneous rupture of a clinically recurrent intracranial dermoid cyst: a case report and narrative review

Hongyuan Liu, Hui Zeng, Bufan Yang, Yuzhu Ji, Zongping Li, Liangxue Zhou

Objective To describe the clinical, pathological, and therapeutic features of spontaneous rupture of a recurrent intracranial dermoid cyst (IDC), and to summarize relevant dermoid-specific literature. Methods We report a 38-year-old woman with a clinical history of resection of a left middle and posterior cranial fossa dermoid cyst more than 10 years earlier. She presented with headache and vomiting, and imaging suggested rupture of a recurrent lesion with cerebrospinal fluid (CSF) dissemination. Emergency microsurgical resection assisted by neuroendoscopy was performed. Six months postoperatively, she developed delayed obstructive hydrocephalus, requiring neuroendoscopic fenestration and lesion debridement. A narrative literature review of ruptured intracranial dermoid cysts (IDCs) was performed, with emphasis on lesions, dissemination patterns, hydrocephalus, treatment, and reported outcomes. Results During the initial emergency surgery, the cyst exhibited paste-like consistency with a thickened capsule. Postoperative pathology confirmed a dermoid cyst. However, disseminated foci remained within the cerebral sulci and ventricles. The second surgery revealed multiple pearl-like lesions within the ventricular system with associated lipid leakage. Following clearance of these lesions, the hydrocephalus resolved. Conclusion Spontaneous rupture of a recurrent IDC is exceptional and may be followed by extensive ventricular dissemination and delayed hydrocephalus. This necessitates a profound understanding of the associated risks, enhanced follow-up protocols, and timely intervention.

View free PDFSource page

Related papers

openalexFrontiers in Oncology2026-07-24

Case Report: Long-term survival in extensive-stage small cell lung cancer treated with adebrelimab-based combination therapy

Xia Y, Yuxian Yang, Wanzhong Huang, Yongshun Chen

The integration of immune checkpoint inhibitors into first-line treatment has markedly improved outcomes for extensive-stage small cell lung cancer (ES-SCLC). Adebrelimab, a PD-L1 inhibitor, demonstrated superior overall survival in the phase 3 CAPSTONE-1 trial. We present a deta…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells

R K Watanabe, Mami Chosei, Haruna Arai, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika

Introduction Neuroendocrine prostate cancer (NEPC) is an aggressive treatment-associated lineage state emerging with potent androgen receptor (AR) pathway inhibition. Although treatment-emergent NEPC is increasingly recognized, the transcriptional consequences of sustained AR sup…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Construction and validation of a machine learning model for predicting anastomotic leak following radical esophagectomy for esophageal cancer

Yueying Yang, Kayishaer Ainiwaer, Yunfei Gao, An Li, Abulajiang Kamili, Dongbo Luo

Background Early identification of patients at high risk of anastomotic leak (AL) following esophagectomy is essential for improving surgical outcomes. However, reliable preoperative risk stratification remains challenging. This study aimed to predict AL risk in the esophageal ca…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth

Gaochao Guo, Yan Sun, Rujun Hong, Yalin Lu, Xingjie Chen, Liming Zhao, et al.

Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a member of the serine/threonine kinase family, is an important oncogene in glioblastoma. IKBKE is involved in the progression of multiple tumours in glioblastoma (GBM), including tumour invasion, migration, and…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies

Ashley R Tetens, Jordyn Craig-Schwartz, Tyler Findlay, Michael A. Koldobskiy

The advent of cancer immunotherapy has led to dramatically improved outcomes in several immunogenic adult cancers. Similar successes have been seen in some pediatric cancers, but only in specific settings. A particular challenge has been the application of immunotherapy approache…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Liver resection is associated with better survival than TACE for hepatocellular carcinoma modestly beyond Milan criteria: a multicenter propensity-matched analysis

Xiaoyan Fan, Guobin Sun, Yong Meng, Liu Xm, Li Zhang, Yan Peng, et al.

Background and aim Liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC) within extended transplant criteria, but it is available to only a minority of patients. The optimal alternative treatment strategy for patients with HCC beyond th…

View free PDFSource page